Michael Lahn

4.7k total citations
114 papers, 3.6k citations indexed

About

Michael Lahn is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Michael Lahn has authored 114 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 48 papers in Molecular Biology and 35 papers in Immunology. Recurrent topics in Michael Lahn's work include Immune Cell Function and Interaction (25 papers), TGF-β signaling in diseases (21 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Michael Lahn is often cited by papers focused on Immune Cell Function and Interaction (25 papers), TGF-β signaling in diseases (21 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Michael Lahn collaborates with scholars based in United States, Germany and Italy. Michael Lahn's co-authors include Willi K. Born, Rebecca L. O’Brien, Erwin W. Gelfand, Ann Cleverly, Arihiko Kanehiro, Akiko Mukasa, Ivelina Gueorguieva, Anthony Joetham, Karim A. Benhadji and Carol Cady and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Michael Lahn

112 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Lahn United States	35	1.6k	1.3k	1.2k	520	477	114	3.6k
Manel Juan Spain	36	1.7k 1.1×	912 0.7×	827 0.7×	380 0.7×	423 0.9×	180	4.1k
Karin Lundberg Sweden	35	1.5k 1.0×	549 0.4×	976 0.8×	480 0.9×	385 0.8×	81	6.4k
Whitney S. Helms United States	20	2.3k 1.5×	968 0.8×	881 0.7×	485 0.9×	228 0.5×	27	4.0k
Christoph Hess Switzerland	37	3.0k 1.9×	1.3k 1.1×	1.6k 1.3×	633 1.2×	354 0.7×	95	5.5k
David B. Sykes United States	30	1.1k 0.7×	649 0.5×	1.7k 1.4×	280 0.5×	216 0.5×	118	3.5k
Keishi Fujio Japan	35	2.2k 1.4×	859 0.7×	848 0.7×	348 0.7×	263 0.6×	208	4.1k
Shinichiro Motohashi Japan	39	3.1k 2.0×	2.2k 1.8×	1.0k 0.8×	529 1.0×	319 0.7×	108	4.9k
Ryuta Nishikomori Japan	34	2.2k 1.4×	438 0.3×	1.7k 1.3×	321 0.6×	498 1.0×	148	4.0k
Reinhold Munker United States	31	1.1k 0.7×	767 0.6×	1.4k 1.1×	246 0.5×	230 0.5×	119	3.7k
Hanns‐Martin Lorenz Germany	35	2.0k 1.3×	500 0.4×	1.0k 0.8×	238 0.5×	235 0.5×	168	4.0k

Countries citing papers authored by Michael Lahn

Since Specialization

Citations

This map shows the geographic impact of Michael Lahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lahn more than expected).

Fields of papers citing papers by Michael Lahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lahn. The network helps show where Michael Lahn may publish in the future.

Co-authorship network of co-authors of Michael Lahn

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lahn. A scholar is included among the top collaborators of Michael Lahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lahn. Michael Lahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giacomo, Anna Maria Di, et al.. (2024). 164P Roginolisib (IOA-244), the first highly selective oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ), has immuno-modulatory effects associated with clinical benefits in patients with metastatic uveal melanoma. Immuno-Oncology Technology. 24. 100793–100793. 1 indexed citations

Pietrobono, Silvia, Federica Fazzini, Valeria Merz, et al.. (2023). Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma. Cancer Research. 84(1). 118–132. 15 indexed citations

Johnson, Zoë, Chiara Tarantelli, Luciano Cascione, et al.. (2023). IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance. Cancer Research Communications. 3(4). 576–591. 10 indexed citations

Conza, Giusy Di, Michael Lahn, Isabel Fabregat, et al.. (2023). Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models. Journal of Experimental & Clinical Cancer Research. 42(1). 197–197. 12 indexed citations

Mair, Maximilian J., Michele Ceccarelli, Andrea Anichini, et al.. (2022). Immunotherapy for brain metastases and primary brain tumors. European Journal of Cancer. 179. 113–120. 13 indexed citations

Mameli, M., et al.. (2022). Validation of an LC–MS/MS method for the quantification IOA-289 in human plasma and its application in a first-in-human clinical trial. Journal of Pharmaceutical and Biomedical Analysis. 217. 114829–114829. 1 indexed citations

Maio, Michele, Christian U. Blank, Andrea Necchi, et al.. (2021). Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!. European Journal of Cancer. 152. 155–164. 23 indexed citations

Lickliter, Jason D., Hui Gan, Mark Voskoboynik, et al.. (2020). <p>A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia</p>. Drug Design Development and Therapy. Volume 14. 1177–1189. 26 indexed citations

Maio, Michele, George Coukos, Soldano Ferrone, et al.. (2018). Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy. Cancer Immunology Immunotherapy. 68(1). 1–9. 8 indexed citations

10.

Saleem, Azeem, Julian C. Matthews, Malcolm Ranson, et al.. (2011). Molecular Imaging and Pharmacokinetic Analysis of Carbon-11 Labeled Antisense Oligonucleotide LY2181308 in Cancer Patients. Theranostics. 1. 290–301. 14 indexed citations

11.

Hahn, Youn‐Soo, Christian Taube, Niyun Jin, et al.. (2004). Different Potentials of γδ T Cell Subsets in Regulating Airway Responsiveness: Vγ1+ Cells, but Not Vγ4+ Cells, Promote Airway Hyperreactivity, Th2 Cytokines, and Airway Inflammation. The Journal of Immunology. 172(5). 2894–2902. 111 indexed citations

12.

Hahn, Youn-Soo, Christian Taube, Niyun Jin, et al.. (2003). Vγ4+ γδ T Cells Regulate Airway Hyperreactivity to Methacholine in Ovalbumin-Sensitized and Challenged Mice. The Journal of Immunology. 171(6). 3170–3178. 64 indexed citations

13.

Kanehiro, Arihiko, Michael Lahn, Mika J. Mäkelä, et al.. (2002). Requirement for the p75 TNF-α Receptor 2 in the Regulation of Airway Hyperresponsiveness by γδ T Cells. The Journal of Immunology. 169(8). 4190–4197. 31 indexed citations

14.

Kanehiro, Arihiko, Toshihide Ikemura, Mika J. Mäkelä, et al.. (2001). Inhibition of Phosphodiesterase 4 Attenuates Airway Hyperresponsiveness and Airway Inflammation in a Model of Secondary Allergen Challenge. American Journal of Respiratory and Critical Care Medicine. 163(1). 173–184. 105 indexed citations

15.

Lahn, Michael, et al.. (2001). T Cell Receptor and Function Cosegregate in Gamma-Delta T Cell Subsets. PubMed. 79. 1–28. 34 indexed citations

16.

Kanehiro, Arihiko, Michael Lahn, Mika J. Mäkelä, et al.. (2001). Tumor Necrosis Factor- α Negatively Regulates Airway Hyperresponsiveness through γδ T Cells. American Journal of Respiratory and Critical Care Medicine. 164(12). 2229–2238. 38 indexed citations

17.

Cady, Carol, Michael Lahn, Michaelann Vollmer, et al.. (2000). Response of Murine γδ T Cells to the Synthetic Polypeptide Poly-Glu50Tyr50 1. The Journal of Immunology. 165(4). 1790–1798. 22 indexed citations

18.

Lahn, Michael, E.John Gallagher, Siu Fai Li, Michael Touger, & Ruben Olmedo. (2000). Prospective Confirmation of Low Arrest Rates among Intoxicated Drivers in Motor Vehicle Crashes. Academic Emergency Medicine. 7(3). 260–263. 4 indexed citations

19.

Lahn, Michael, Harshan Kalataradi, Michaelann Vollmer, et al.. (1998). Early preferential stimulation of gamma delta T cells by TNF-alpha.. PubMed. 160(11). 5221–30. 89 indexed citations

20.

Mackensen, Andréas, Hendrik Veelken, Michael Lahn, et al.. (1997). Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts. Journal of Molecular Medicine. 75(4). 290–296. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact